Andrew Cohen, MD
Cardiovascular Disease · Aurora, CONPI 1750377545
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 128 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Abbott at 55.8% of the total. Reporting peaked in 2019 at $1,103 and has fallen 75.0% since, to $275 in 2024.
Across 128 payments — averaging $22.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$517
- Medtronic$194
- E.r. Squibb & Sons, L.L.C.$135
- Amgen$114
- Biosense Webster, Inc.$72
- plus $232 from 8 others
Across 24 payments — averaging $698.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boehringer Ingelheim Pharma GmbH & Co.kg$14K
- Abbott$2K
- Boehringer Ingelheim$625
- Boehringer Ingelheim International GmbH$606
What the payments were for
- Food & beverage$2,863100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 59 | $1,599 |
| Boston Scientific | 23 | $517 |
| Medtronic(2 entities) | 9 | $194 |
| E.r. Squibb & Sons, L.L.C. | 10 | $135 |
| Amgen | 7 | $114 |
| Biosense Webster, Inc. | 5 | $72 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Pfizer | 4 | $54 |
| Johnson & Johnson | 2 | $31 |
| Cardiva Medical, Inc. | 1 | $21 |
| Gilead | 1 | $19 |
| Preventice Services, LLC | 1 | $17 |
| Biotronik Inc. | 1 | $16 |
| Boehringer Ingelheim | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ensite Cardiac Mapping System$174
- ENSITE$160
- RESONATE$123
How this compares
$2,863 in reported general payments places this provider in the 60th percentile of 276 cardiovascular disease providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Aurora
- Payal KohliAurora$1.7M
- Marc BonacaAurora$703K
- William SauerAurora$365K
- Rhonda MiyasakaAurora$128K
- Gregory SchwartzAurora$122K
- Edward GillAurora$96K
- Joseph AdewumiAurora$61K
- Charles FuenzalidaAurora$30K
- Christina HealyAurora$25K
- Sundeep ViswanathanAurora$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.